Relyea Zuckerberg Hanson LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 7.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,021 shares of the company’s stock after acquiring an additional 283 shares during the period. Relyea Zuckerberg Hanson LLC’s holdings in Colgate-Palmolive were worth $366,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $53,000. Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive in the third quarter worth $64,000. True Wealth Design LLC raised its position in shares of Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC grew its position in Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after buying an additional 368 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
CL has been the topic of several recent analyst reports. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Piper Sandler lowered their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. TD Cowen cut their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $105.00 to $101.00 in a report on Monday, October 28th. Finally, JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $102.11.
Insider Activity
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.37% of the company’s stock.
Colgate-Palmolive Trading Up 0.2 %
Shares of Colgate-Palmolive stock traded up $0.16 on Friday, hitting $88.72. The stock had a trading volume of 681,324 shares, compared to its average volume of 4,618,708. The stock’s 50-day simple moving average is $92.32 and its two-hundred day simple moving average is $97.85. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The stock has a market cap of $72.48 billion, a price-to-earnings ratio of 25.41, a PEG ratio of 3.01 and a beta of 0.44.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is the Nasdaq? Complete Overview with History
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
- Best Aerospace Stocks Investing
- Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.